{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:22:43Z","timestamp":1790612563521,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ejmech.2019.04.067","type":"journal-article","created":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T18:08:50Z","timestamp":1556474930000},"page":"287-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"175","author":[{"given":"Srikanth","family":"Gatadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Gour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjulika","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunava","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.V.","family":"Madhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8823-6074","authenticated-orcid":false,"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6671-2022","authenticated-orcid":false,"given":"Srinivas","family":"Nanduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.04.067_bib1a","doi-asserted-by":"crossref","first-page":"16187","DOI":"10.1038\/nmicrobiol.2016.187","article-title":"Combating antimicrobial resistance globally","volume":"1","author":"Sugden","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2019.04.067_bib1b","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1469-0691.2008.02074.x","article-title":"Healthcare-associated infections: think globally, act locally","volume":"14","author":"Marcel","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2019.04.067_bib1c","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/520193","article-title":"Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2","volume":"29","author":"Fridkin","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.04.067_bib2a","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-0711-12-22","article-title":"New antibiotics for bad bugs: where are we?","volume":"12","author":"Bassetti","year":"2013","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.ejmech.2019.04.067_bib2b","first-page":"127","article-title":"Capsule commentaries: drug reaction considerations with oral minocycline, SKIN","volume":"2","author":"Del Rosso","year":"2018","journal-title":"J.\u00a0Cutan. Med."},{"key":"10.1016\/j.ejmech.2019.04.067_bib3a","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1073\/pnas.122108599","article-title":"The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"99","author":"Enright","year":"2002","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2019.04.067_bib3b","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm.Ther."},{"key":"10.1016\/j.ejmech.2019.04.067_bib3c","volume":"vols. 1\u20137","author":"Tacconelli","year":"2017"},{"key":"10.1016\/j.ejmech.2019.04.067_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/hs.2014.0088","article-title":"Antimicrobial resistance is a global health emergency","volume":"13","author":"Toner","year":"2015","journal-title":"Health secur."},{"key":"10.1016\/j.ejmech.2019.04.067_bib5a","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1574-6968.1992.tb05089.x","article-title":"Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus","volume":"93","author":"Noble","year":"1992","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejmech.2019.04.067_bib5b","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ejmech.2019.04.067_bib5c","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","article-title":"Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance","volume":"1","author":"Hiramatsu","year":"2001","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.04.067_bib5d","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus","volume":"340","author":"Smith","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.04.067_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2019.04.067_bib7a","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","article-title":"Development of daptomycin resistance in\u00a0vivo in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Hayden","year":"2005","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2019.04.067_bib7b","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijmm.2017.12.002","article-title":"Differential daptomycin resistance development in Staphyloccocus aureus strains with active and mutated gra regulatory systems","volume":"308","author":"M\u00fcller","year":"2017","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ejmech.2019.04.067_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02397-17","article-title":"Antimicrobial activity of dalbavancin against Staphylococcus aureus with decreased susceptibility to glycopeptides, daptomycin, and\/or linezolid from U.S. medical centers","volume":"62","author":"Sader","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.04.067_bib9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1574-6976.2003.tb00628.x","article-title":"Mechanism of action of oritavancin and related glycopeptide antibiotics","volume":"26","author":"Allen","year":"2003","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2019.04.067_bib10a","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1128\/AAC.05004-14","article-title":"Ceftobiprole-and ceftaroline-resistant methicillin-resistant Staphylococcus aureus","volume":"59","author":"Chan","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.04.067_bib10b","first-page":"983","article-title":"Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime","volume":"23","author":"Bazan","year":"2009","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.ejmech.2019.04.067_bib11a","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.lpm.2017.01.015","article-title":"Tuberculosis elimination and the challenge of latent tuberculosis","volume":"46","author":"Matteelli","year":"2017","journal-title":"Presse Med."},{"key":"10.1016\/j.ejmech.2019.04.067_bib11b","series-title":"Official American thoracic society\/centers for disease control and prevention\/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis, clinical infectious diseases","first-page":"e147","volume":"63","author":"Nahid","year":"2016"},{"key":"10.1016\/j.ejmech.2019.04.067_bib12a","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11030-017-9792-1","article-title":"Synthesis of novel (E)-2-(4-(1H-1, 2, 4-triazol-1-yl) styryl)-4-(alkyl\/arylmethyleneoxy) quinazoline derivatives as antimicrobial agents","volume":"22","author":"Yang","year":"2018","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2019.04.067_bib12b","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.micpath.2018.02.018","article-title":"In\u00a0vitro evaluation of new 2-phenoxy-benzo [g][1, 2, 4] triazolo [1, 5-a] quinazoline derivatives as antimicrobial agents","volume":"117","author":"Abuelizz","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejmech.2019.04.067_bib12c","first-page":"134","article-title":"Synthesis and evaluation of antifungal activities of (3H)-quinazolin-4-one derivatives against tree plant fungi","volume":"8","author":"Ighachane","year":"2017","journal-title":"J.\u00a0Mater. Environ. Sci."},{"key":"10.1016\/j.ejmech.2019.04.067_bib13a","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.ejmech.2011.03.015","article-title":"Synthesis and in\u00a0vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent","volume":"46","author":"Noolvi","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib13b","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1021\/acs.jmedchem.7b01474","article-title":"Quinazolinone based anticancer agents: synthesis, antiproliferative SAR, antitubulin activity, and tubulin co-crystal structure","volume":"61","author":"Dohle","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib13c","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s11164-017-3245-4","article-title":"Synthesis and anticancer activity of novel quinazolinone and benzamide derivatives","volume":"44","author":"EI","year":"2018","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejmech.2019.04.067_bib13d","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00044-017-2083-7","article-title":"New series of 4 (3H)-quinazolinone derivatives: syntheses and evaluation of antitumor and antiviral activities","volume":"27","author":"Abbas","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.04.067_bib14a","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.fitote.2017.05.001","article-title":"Pharmaceutical prospects of naturally occurring quinazolinone and its derivatives","volume":"119","author":"Hea","year":"2017","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2019.04.067_bib14b","first-page":"083","article-title":"Design, synthesis and preliminary pharmacological screening (antimicrobial, analgesic and anti-inflammatory activity) of some novel quinazoline derivatives","volume":"7","author":"Dash","year":"2017","journal-title":"J.\u00a0Appl. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.04.067_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1871524917666170104142033","article-title":"Synthesis, Molecular docking and evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1,3] oxazin\/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one derivatives for their anticonvulsant activity","volume":"18","author":"Jain","year":"2018","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib16","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.bmcl.2017.05.064","article-title":"Synthesis and structure\u2013activity relationship study of novel quinazolinone based inhibitors of Mur A","volume":"27","author":"Hrast","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.04.067_bib17","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1016\/j.ejmech.2009.05.008","article-title":"Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl\/ethyl-4H-quinazolin-3-yl)-urea","volume":"44","author":"Kashawa","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib18a","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.bmc.2016.03.031","article-title":"Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: an update on the development of synthetic methods and pharmacological diversification","volume":"24","author":"Khan","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib18b","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejmech.2014.02.005","article-title":"Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: synthetic approaches and multifarious applications","volume":"76","author":"Khan","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib18c","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejmech.2014.10.084","article-title":"Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: the advances continue","volume":"90","author":"Khan","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib19a","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molstruc.2017.11.087","article-title":"Synthesis, spectroscopic characterization, antimicrobial evaluation and molecular docking study of novel triazine-quinazolinone based hybrids","volume":"1156","author":"Dinari","year":"2018","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2019.04.067_bib19b","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ejmech.2016.05.066","article-title":"Synthesis, anti-inflammatory, analgesic, COX-1\/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4 (3H)-quinazolinones","volume":"121","author":"Alaa","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201700513","article-title":"Synthesis, cytotoxic, and antibacterial evaluation of quinazolinone derivatives with substituted amino moiety","volume":"15","author":"Zhan","year":"2018","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2019.04.067_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jsps.2013.03.004","article-title":"Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents","volume":"22","author":"Zayed","year":"2014","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.ejmech.2019.04.067_bib22a","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1248\/bpb.26.1711","article-title":"Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-Methyl-3-substituted quinazolin-4-(3H)-ones","volume":"26","author":"Alagarsamy","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2019.04.067_bib22b","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00044-012-0037-7","article-title":"Synthesis, analgesic, anti-inflammatory, and in\u00a0vitro antimicrobial activities of some novel quinazolin-4 (3H)-one derivatives","volume":"22","author":"Saravanan","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.04.067_bib23a","first-page":"293","article-title":"Synthesis and anti-tubercular activity of Mannich bases of 2-methyl-3H-quinazolin-4-ones","volume":"15","author":"Nandy","year":"2006","journal-title":"Indian J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib23b","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ejmech.2018.03.076","article-title":"An overview of quinazolines: pharmacological significance and recent developments","volume":"151","author":"Alagarsamy","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib24","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.bmcl.2016.04.012","article-title":"Synthesis, biological evaluation and structure\u2013activity relationship of 2-styrylquinazolones as anti-tubercular agents","volume":"26","author":"Jadhavar","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.04.067_bib25","first-page":"804","volume":"65","author":"Desai","year":"1988","journal-title":"J.\u00a0Indian Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.04.067_bib26","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1021\/acs.jmedchem.6b00372","article-title":"Structure\u2013activity relationship for the 4 (3 H)-Quinazolinone antibacterials","volume":"59","author":"Bouley","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib27a","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bioorg.2018.11.007","article-title":"Synthesis and evaluation of new 4-oxoquinazolin-3(4H)-yl)benzoic acid and benzamide derivatives as potent antibacterial agents effective against multidrug resistant Staphylococcus aureus","volume":"83","author":"Gatadi","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib27b","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bioorg.2018.08.012","article-title":"Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA)","volume":"81","author":"Gatadi","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib28","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1016\/j.tet.2014.07.016","article-title":"C-Triazolyl \u03b2-d-furanosides as LpxC inhibitors: stereoselective synthesis and biological evaluation","volume":"70","author":"Jana","year":"2014","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2019.04.067_bib29","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jgar.2017.04.003","article-title":"In\u00a0vitro activity of ceftolozane\/tazobactam in combination with other classes of antibacterial agents","volume":"10","author":"Jacqueline","year":"2017","journal-title":"J.\u00a0Glob. Antimicrob. Resist."},{"key":"10.1016\/j.ejmech.2019.04.067_bib30a","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.steroids.2010.02.015","article-title":"D-ring substituted 1, 2, 3-triazolyl 20-keto pregnenanes as potential anticancer agents: synthesis and biological evaluation","volume":"75","author":"Banday","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2019.04.067_bib30b","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.ejmech.2017.10.042","article-title":"Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates","volume":"143","author":"Faidallah","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib31","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ejmech.2018.08.070","article-title":"Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus","volume":"157","author":"Gatadi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.067_bib32","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard, Ninth ed., CLSI Document M07-A9","author":"Wayne","year":"2012"},{"key":"10.1016\/j.ejmech.2019.04.067_bib33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/510431","article-title":"New consensus guidelines from the clinical and laboratory standards institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria","volume":"44","author":"Jorgensen","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.04.067_bib34a","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1038\/s41598-017-11575-5","article-title":"Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity","volume":"7","author":"Pandey","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.04.067_bib34b","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2019.04.067_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","article-title":"Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis","volume":"41","author":"Rivas-Santiago","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2019.04.067_bib36","first-page":"38","article-title":"In-vitro cytotoxicity activity of Solanum nigrum extract against Hela cell line and Vero cell line","volume":"1","author":"Patel","year":"2009","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.04.067_bib37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijantimicag.2017.03.020","article-title":"Repurposing Ivacaftor for treatment of Staphylococcus aureus infections","volume":"50","author":"Thakare","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2019.04.067_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.04.067_bib39","article-title":"Static biofilm cultures of Gram-positive pathogens grown in a microtiter format used for anti-biofilm drug discovery","volume":"13","author":"Kwasny","year":"2010","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.04.067_bib40","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1046\/j.1365-2672.2002.01594.x","article-title":"The antibacterial activity of vancomycin towards Staphylococcus aureus under aerobic and anaerobic conditions","volume":"92","author":"Suller","year":"2002","journal-title":"J.\u00a0Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2019.04.067_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/27.suppl_C.29","article-title":"Pharmacodynamics of amikacin in\u00a0vitro and in mouse thigh and lung infections","volume":"27","author":"Craig","year":"1991","journal-title":"J.\u00a0Antimicrob. Chemother"},{"key":"10.1016\/j.ejmech.2019.04.067_bib42","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1128\/AAC.01666-13","article-title":"Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection","volume":"58","author":"Wang","year":"2014","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419303952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419303952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:55:16Z","timestamp":1759326916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419303952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":67,"alternative-id":["S0223523419303952"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.04.067","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.04.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}